Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cholesterol side-chain cleavage enzyme, P450scc, initiates biosynthesis of all steroid hormones. Adrenal and gonadal P450scc expression requires steroidogenic factor-1 (SF1), but P450scc expression in human placental JEG-3 cells utilizes an SF1-independent element at -155/-131 that is inactive in adrenals and gonads. We previously cloned two transcription factors, long terminal repeat binding protein (LBP)-1b and
LBP-9
, from JEG-3 cells. In transient transfection assays, LBP-1b activated the -155/-131 element whereas
LBP-9
suppressed its LBP-1b-stimulated expression. To assess the roles of these factors on the intact P450scc gene, we stably expressed LBP-1b or
LBP-9
in JEG-3 cells. All cell lines stably expressing a fusion protein of LBP-1b and enhanced green fluorescent protein increased P450scc expression, but cell lines stably expressing
LBP-9
fused to enhanced green fluorescent protein either increased or decreased P450scc expression. 8-Br-cAMP induced endogenous
LBP-9
, but not LBP-1b expression. Glutathione-S-transferase pull-down assays showed that LBP-1b and
LBP-9
can dimerize with themselves and with each other; LBP-1b residues 300-540 and
LBP-9
residues 300-479 were required for dimer formation. Glutathione-S-transferase pull-down assays, bandshifts, and transient transfection assays showed that TReP-132 (another factor that can bind to -155/-131) does not interact with either LBP-1b or
LBP-9
, or influence their ability to induce or suppress transcription from the -155/-131 element. Gal4 transactivation assays showed that transcriptional repression activity by
LBP-9
requires residues 100-200. RNAi interference of either LBP-1b or
LBP-9
mRNAs decreased P450scc expression. LBP-1b is an important SF1-independent
transcriptional activator
stimulating P450scc expression in human placental JEG-3 cells, whereas
LBP-9
modulates the action of LBP-1b, exerting both positive and negative effects.
...
PMID:LBP proteins modulate SF1-independent expression of P450scc in human placental JEG-3 cells. 1547 45